|
Renovis
Renovis is a biopharmaceutical
company developing drugs to treat neurological diseases and disorders. We are
currently pursuing six distinct programs, including two product candidates in
clinical development. Our most advanced candidate is Cerovive®, an
intravenous drug being evaluated for the treatment of acute ischemic stroke. Our
exclusive licensee, AstraZeneca, is currently studying Cerovive in a Phase III
clinical trial program. We are also independently developing REN-1654, an oral
drug for neuropathic pain in Phase II clinical trials.
The Renovis team is dedicated to
meeting the company's goal—to become the leading biopharmaceutical company
focused on discovering, developing, and commercializing drugs to treat
neurological diseases and disorders.
If you are interested in joining our
team, please send your resume to:
Human
Resources
Renovis, Inc.
Two Corporate Drive
South San Francisco, CA 94080-7047
650.266.1400 [main]
650.266.1505 [fax]
jobs@renovis.com
web: http://www.renovis.com
|